Connect with us

Hi, what are you looking for?

Tech

Sweden to give 12-15 year olds Pfizer vaccine, rejects Moderna

The European Medicines Agency approved the use of Comirnaty in May, while Spikevax was given the nod for children over 12 in July
STOCKHOLM: Sweden’s Public Health Agency said on Monday it recommended the use of Pfizer-BioNTech’s , Comirnaty vaccine against COVID-19 for children between 12-15, opting against rival Moderna’s Spikevax. The European Medicines Agency approved the use of Comirnaty in May, while Spikevax was given the nod for children over 12 in July. “All in all, we see reason to choose the vaccine that we know the most about and that is most well-proven when it comes to vaccinating children between 12 and 15 years of age,” Anders Tegnell, head of department and state epidemiologist at the Health Agency said. The agency said there was more data about Comirnaty’s use on children. “That’s why Spikevax is not recommended for the youngest age group in Sweden,” the Agency said in a statement. In September, the Agency said that children aged 12 and over would be offered a COVID vaccination starting October 11.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

BEST PICKS FOR YOU

I’m going to let you in on a little secret. I got a $750 SHEIN gift card this week and all I had to...

Politics

World3 hours ago (Sep 22, 2021 06:26PM ET) (C) Reuters. FILE PHOTO: Signage is seen at the United States Department of the Treasury headquarters...

World News

Customers of HSBC in Wales may soon be able to ask for a loan in their native language after the global bank announced...

Stock

Stock Markets5 minutes ago (Sep 23, 2021 05:05PM ET) (C) Reuters. FILE PHOTO: Richard Li, Hong Kong businessman and younger son of tycoon Li...

Disclaimer: Wisegazette.com it's managers and its employees (collectively "The Company") do not make any guarantee or warranty about what is advertised or above. Information provided by this website is for research purposes only and should not be considered as personalized financial or health advice. Copyright © 2021 Wise Gazette. All Rights Reserved